Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 532
Selected: 0
NCT IDTitle
NCT05587452Early Screening of Colorectal Cancer Based on Plasma Multi-omics Combining With Artificial Intelligence
NCT06202014Phase II Study of Concurrent Radiotherapy With Envafolimab and Capecitabine in LAPC
NCT06544668A Study for Dynamic Prediction Model of Breast Cancer Bone Metastases
NCT00700440Study of Cetuximab in Nasopharyngeal Carcinoma (NPC) With Chemoradiotherapy
NCT03009253Translational Research on Locally Advanced Pancreatic Adenocarcinoma
NCT06483672Furmonertinib Combined With Anlotinib in Lung Adenocarcinoma Patients With EGFR Mutations and Brain Metastases
NCT07476677Darolutamide ± ADT as Neoadjuvant Therapy in High-Risk/Very High-Risk Localized Prostate Cancer
NCT05050630Phase II Trial of Tirelizumab Combined With R2-ICE Regimen in the Treatment of rrDLBCL/HGBL
NCT07107815A Study On The Prediction of Neoadjuvant Efficacy For Rectal Cancer Based On MR Cytometry Imaging and Deep-radiomics
NCT04571476Diagnostic Value of UTB and TB for PPL
NCT05351346Genotype-guided Treatment in DLBCL
NCT06289023HA-WBRT-SIB for Brain Metastasis of Lung Cancer
NCT06084897Radiotherapy in Patients With Metastatic Esophageal Cancer Responding to PD-1 Inhibitor Plus Chemotherapy
NCT03637634The Children and Adolescents Nasopharyngeal Carcinoma Survivor Study
NCT07117864Exploration of the Safety and Efficacy of T-DXd Concurrent With Brain Radiotherapy in Patients With Brain Metastases HER2-positive/HER2-low Advanced Breast Cancer
NCT06959732Zanubrutinib Combined With G-CVP in Previously Untreated FL
NCT01637493Pharmacokinetics and Pharmacodynamics Study of Pegfilgrastim in Chemotherapy Patients
NCT03955367Pelvic RT Versus Prophylactic Extended-field RT in Patients With Cervical Cancer
NCT06757621Hypofractionated Postoperative Regional Nodal Irradiation for Patients With Intermediate-risk Breast Cancer
NCT06457906SRS/SRT/Hypo-RT Versus HA-WBRT for No More Than 10 Brain Metastases in SCLC
NCT02691871Apatinib Plus Docetaxel as 2nd Line Treatment in Patients With Advanced Lung Adenocarcinoma Harboring Wild-type EGFR
NCT07048964A Prospective Cohort Study of Pralsetinib or Anlotinib in the Treatment of Locally Advanced and/or Metastatic Medullary Thyroid Carcinoma With RET Gene Mutations
NCT03874871Function Preserving Gastrectomy for T1/2 Gastric Cancer Patients
NCT06513364Neoadjuvant Chemotherapy With WH002 in Women With HER2-negative Breast Cancer
NCT06612632Immunotherapy Rechallenge in Patients with Solid Tumors in Clinical Trials
NCT07380230Efficacy and Safety of Qibei Jiedu Formula for Preventing and Managing Acute Radiation Dermatitis in Breast Cancer Patients
NCT06857305Efficacy and Safety of Biweekly Regimen of Eribulin Versus a Standard Regimen for the Treatment of Locally Recurrent or Metastatic HER2-negative Breast Cancer: a Multicenter, Randomized, Open-label, Phase III Trial
NCT03791125Phase I Single-dose Escalation Clinical Trial of Salvianolic Acid A Tablets
NCT02943252The Clinical Study of Apatinib Plus S1 for Patients With Advanced Non-squamous Head and Neck Cancer
NCT05283616Reduced Dose of Pegfilgrastim as Support for Chemotherapy for Breast Cancer
NCT03308552Radiotherapy With or Without Concurrent Chemotherapy for Limited Lymphatic Metastasis of Esophageal Cancer - 3JECROG P-02
NCT04671303To Evaluate the Efficacy and Safety of Anlotinib Combined With Furmonertinib Mesylate in Lung Cancer
NCT05009017Multi-Centre, Observational Study on Safety of Bevacizumab Biosimilars in Clinical Practice Among Chinese Patients
NCT06490107Durvalumab Combined With S-1 as Adjuvant Therapy of Resectable BTC
NCT04498793Study of Tislelizumab Plus Chemotherapy vs Chemotherapy as Perioperative Treatment in Participants With HER2 Negative Breast Cancer
NCT02487316A Study of Treatment ALK(+) Systemic Anaplastic Large Cell Lymphoma With Crizotinib
NCT04543695A Study of Total Neoadjuvant Therapy for High-risk Locally Advanced Rectal Cancer
NCT05747313Chidamide in Combination With Vincristine Metronomic Chemotherapy for Advanced Triple-negative Breast Cancer
NCT06034964Tislelizumab Combined With Chemotherapy in First-line Treatment of AGC
NCT05777824Postoperative Management for HNSCC Based on Pathological Response of Induction Chemotherapy and Immunotherapy
NCT02832271Green Tea Extract for Endometriosis Treatment
NCT02500810Monosialoganglioside Preventing Neurotoxicity Induced by Albumin-bound Paclitaxel Chemotherapy in Lung Cancer Patients
NCT05443646Consolidation Serplulimab Following Concurrent Chemoradiotherapy for LS-SCLC Patients
NCT03708042A Study to Compare Efficacy and Safety of DRT VS CRT Plus Surgery in Patients Who Achieved CCR for Esophageal Cancer
NCT06610227A Study of the RNA Tumor Vaccine Targeting MICA/B in Patients With Advanced Solid Tumors
NCT06543069Sintilimab, Bevacizumab, Pemetrexed, and Cisplatin for Unresectable MPeM
NCT06598839Immuno-effect of Tα1 for Stage I NSCLC
NCT07189572Intranasal Corticosteroid Spray for Preventing Otitis Media With Effusion After Radiotherapy in Nasopharyngeal Carcinoma
NCT05892354Effect of Immunonutrients on Oral Mucositis in Nasopharyngeal Carcinoma Patients After Chemoradiotherapy
NCT01492556Study of Etoposide in Treating Patients With Recurrent or Metastatic Breast Cancer